Literature DB >> 20121393

Longitudinal study of CD4+ cell counts in HIV-negative pregnant patients.

Craig V Towers1, Pamela J Rumney, Mark G Ghamsary.   

Abstract

OBJECTIVE: To evaluate the absolute CD4+, CD8+, and lymphocyte cell counts and percentages from the first trimester through 6-12 weeks post-delivery in normal human immunodeficiency virus (HIV)-negative pregnant patients.
METHODS: A longitudinal laboratory analysis was performed during pregnancy that involved 51 HIV-negative subjects with blood analysis obtained in all trimesters, at delivery, and 6-12 weeks post-delivery. Twenty-five HIV-negative non-pregnant controls were also evaluated. Blood was analysed for absolute CD4+, CD8+, and lymphocyte cell counts and percentages. Means, standard deviations, trends, and differences were examined.
RESULTS: The mean white blood cell (WBC) count is elevated above the non-pregnant state and this parameter increases through the pregnancy up to and including parturition. The mean absolute lymphocyte cell count, lymphocyte percentage, and absolute CD4+ cell count are significantly lower during pregnancy and the progression through pregnancy appears U-shaped. The mean absolute CD8+ cell count is not significantly different. The CD4+ and CD8+ percentages are higher during pregnancy and this elevation persists into the 6-12 week post-delivery time period. A 3-digit drop in CD4+ percentage is common during pregnancy between blood draws; whereas, a 30% decrease or more in absolute CD4+ cell count is rare.
CONCLUSIONS: By longitudinal analysis, pregnancy appears to significantly elevate the mean values of the WBC count, CD4+ percentage, and CD8+ percentage, but significantly decreases the absolute lymphocyte count, lymphocyte percentage, and absolute CD4+ cell count when compared to non-pregnant controls. The mean absolute CD8+ cell count appears to be unaffected.

Entities:  

Mesh:

Year:  2010        PMID: 20121393     DOI: 10.3109/14767050903580359

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

Review 1.  Diagnostic Value of Interferon-Gamma Release Assays for Tuberculosis in the Immunocompromised Population.

Authors:  Ying Yang; Hong-Jiao Wang; Wei-Lin Hu; Guan-Nan Bai; Chun-Zhen Hua
Journal:  Diagnostics (Basel)       Date:  2022-02-10

2.  Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.

Authors:  C D Zorrilla; R Wright; O O Osiyemi; S Yasin; B Baugh; K Brown; B Coate; P Verboven; J Mrus; R Falcon; T N Kakuda
Journal:  HIV Med       Date:  2013-06-03       Impact factor: 3.180

3.  Establishment of Immunohematological Reference Values among HIV Sero-negative Pregnant Women at St. Paul's Hospital Millennium Medical College (SPHMMC), Addis Ababa, Ethiopia.

Authors:  Addisu Gize Yeshanew; Yeshwondm Mamuye GebreSilasie; Hirut Tadesse Mengesha
Journal:  Ethiop J Health Sci       Date:  2017-11

4.  Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.

Authors:  John König Walles; Fregenet Tesfaye; Marianne Jansson; Taye Tolera Balcha; Niclas Winqvist; Mestawet Kefeni; Sileshi Garoma Abeya; Feleke Belachew; Erik Sturegård; Per Björkman
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

5.  Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study.

Authors:  Olayemi Osiyemi; Salih Yasin; Carmen Zorrilla; Ceyhun Bicer; Vera Hillewaert; Kimberley Brown; Herta M Crauwels
Journal:  Infect Dis Ther       Date:  2018-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.